NAB (ASX:NAB) full year profits fell 10.6 per cent
07 Nov 2019 - NAB (ASX:NAB) report their full year profits fell 10.6 per cent to $5.1 billion
07Nov
07Nov
James Hardie (ASX:JHX) raises its FY adjusted NOPAT: ASX poised to open higher
07 Nov 2019 - Despite weak leads from US markets, the ASX looks set to open higher. Wall Street shares dropped after it was reported that President Donald Trump and Chinese President Xi Jinping’s meeting to sign an interim trade deal could be delayed until December. James Hardie (ASX:JHX) raised its full year adjusted net operating profit guidance.
07Nov
nib Group (ASX:NHF) reaffirms its FY20 guidance
07 Nov 2019 - nib Group (ASX:NHF) reaffirmed its financial year 2020 underlying operating profit guidance of at least $200 million, with statutory operating profit of at least $180 million.
07Nov
South32 (ASX:S32) agree to divest SA Energy Coal
07 Nov 2019 - South32 (ASX:S32) have entered into a binding conditional agreement for the sale of their 91.84 per cent shareholding in South32 SA Coal Holdings Proprietary.
06Nov
Macquarie downgrades Blackmores: Aus shares close 0.6% lower
06 Nov 2019 - Following a steady decline over the afternoon the S&P/ASX200 closed 0.6 per cent lower. Macquarie downgraded Blackmores (ASX:BKL) as an Underperform and reduces its 12-month price target to $58. Corporate Travel Management (ASX:CTD) confirmed its expectation for a 10 to 16.5% increase in EBITDA YoY.
06Nov
Pendal Group (ASX:PDL) tops best performers list: Aus shares flat at noon
06 Nov 2019 - The Australian share market opened lower despite positive leads from Wall Street and is now tracking flat at noon. Pendal Group (ASX:PDL) has topped the ASX best performers list despite a 23.5% decrease in NPAT compared to the prior corresponding period and a broker downgrade from Morgan Stanley.
06Nov
Immutep (ASX:IMM) reports positive trial data
06 Nov 2019 - Immutep Limited (ASX:IMM) CEO, Marc Voigt provides an update on the company's clinical trial data for its Phase 1 trial in melanoma, TACTI-mel, where patients are responding positively to the combination therapy of efti and Keytruda.
06Nov
State Gas (ASX:GAS) – Bowen Basin gas developer
06 Nov 2019 - State Gas Limited (ASX:GAS) Executive Chairman, Richard Cottee provides an update on the company's key Reid’s Dome PL 231 gas project, drill program and timeline to production.
06Nov
James Hardie (ASX:JHX) appoints new director
06 Nov 2019 - James Hardie Industries (ASX:JHX) has appointed Dr Moe Nozari as an independent non-executive director effective 6 November 2019.
06Nov
Bubs (ASX:BUB) inks strategic agreement with Alibaba
06 Nov 2019 - Bubs Australia (ASX:BUB) has inked a strategic agreement with Alibaba Centralised Import Procurement to capitalise on the growth of China’s goat dairy market.